COVID-19 Impact on Qiagen NV’s Revenue and Operations (Medical Devices)
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Qiagen provides molecular testing solutions including instruments, consumables and automation systems for molecular diagnostics, applied testing, pharma and academia markets worldwide. It provides solutions to more than 500,000 customers across the world. Qiagen is a provider of molecular testing solutions. Qiagen's product range include Sample Technologies, Assay Technologies, Assay Instruments, Next-Generation Sequencing Consumables, Forensics Sample Collection Consumables and Laboratory and Genomic Services. The report, COVID-19 Impact on Qiagen NV's Revenue and Operations (Medical Devices) presents a deep dive analysis into how Qiagen NV is placed to respond to the COVID-19 crisis, by examining its sector performance and competitiveness.
Scope
The report provides a comprehensive analysis of the impact of COVID-19 on Qiagen NV –
– It provides insights on Qiagen NV's exposure to the regions and businesses impacted by the COVID-19 outbreak.
– It offers an overview of the company’s revenue impact by region and market for 2020 due to the COVID-19 outbreak.
Key Highlights
Net sales for Q3 2020 increased by 26%, likely driven by an ongoing very high level of sales for product groups used in the COVID-19 pandemic response and rapid test kits.
Qiagen’s production capacity for RNA extraction reagents exceeded to more than the previously expected 10 million patient samples per month. Qiagen is also ramping up its capacity for production of QIAsymphony automation systems and QIAcube processing units due to high demand.
Qiagen continues its increase in production of QIAstat syndromic system, QIAstat-Dx Respiratory SARS-CoV-2 Panel and NeuMo-Dx in the U.S, Europe and other countries due to its high demand.
Despite the heavy impact in Europe and the rapid rise of COVID-19 cases in the US, Qiagen saw a significant increase in its total revenue specifically in the Life Science and Molecular segments.
Reasons to Buy
An overview of how Qiagen NV will be affected by the COVID-19 pandemic.
Table of Contents
Frequently asked questions
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.